Concepedia

Qinggang Tian

QT

Statistics

Publications

5

Citations

116

H-Index

5

Active since

2016

Affiliations

Central South University(Current)

Baotou Central Hospital

Baotou Medical College

Xiangya Hospital Central South University

Inner Mongolia Medical University

Qinggang Tian is an author at Central South University specializing in molecular oncology, oncology, and medicine.

Publications per year

2016–2021

5

Publications

5

THBS2 is a biomarker for AJCC stages and a strong prognostic indicator in colorectal cancer.

Qinggang Tian, Yun Liu, Yuguo Zhang et al. · PubMed · 2019 · 37 citations

, , +17

MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor

Liansheng Gong, Qinggang Tian, Jiantai He et al. · OncoTargets and Therapy · 2016 · 22 citations · Full text

, , +17

MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression

Qinggang Tian, Yao Xiao, Yanting Wu et al. · International Journal of Molecular Medicine · 2016 · 22 citations · Full text

, , +17

[Retracted] MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression

Qinggang Tian, Yao Xiao, Yanting Wu et al. · International Journal of Molecular Medicine · 2021 · 20 citations · Full text

, , +14

IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma

Chunyan Yue, Manyi Yang, Qinggang Tian et al. · Artificial Cells Nanomedicine and Biotechnology · 2018 · 15 citations · Full text

, , +17

1–5 of 5